Mesa Laboratories, Inc. (MLAB) News

Mesa Laboratories, Inc. (MLAB): $199.66

1.64 (+0.83%)

POWR Rating

Component Grades













Filter MLAB News Items

MLAB News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest MLAB News From Around the Web

Below are the latest news stories about Mesa Laboratories Inc that investors may wish to consider to help them evaluate MLAB as an investment opportunity.

Mesa Laboratories Non-GAAP EPS of $1.36 beats by $0.04, revenue of $54.69M beats by $10.22M

Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $1.36 beats by $0.04.Revenue of $54.69M (+60.1% Y/Y) beats by $10.22M.

Seeking Alpha | February 3, 2022

Mesa Labs (MLAB) Q3 Earnings Miss Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -19.05% and 13.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 3, 2022

Are Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Mixed Financials Driving The Negative Sentiment?

Mesa Laboratories (NASDAQ:MLAB) has had a rough month with its share price down 15%. It is possible that the markets...

Yahoo | February 3, 2022

Mesa Labs Announces Third Quarter Results

LAKEWOOD, Colo., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for its third fiscal quarter (“3Q22”) and nine months ended December 31, 2021. Financial highlights for the quarter and nine months ended December 31, 2021 as compared to the same periods last year: Revenues increased 60% and 31%, respectivelyOperating (loss) income decreased $2,534 and $3,250, respectivelyNon-GAAP adjusted operating income¹ excluding unusual items increased $5,794 or

Yahoo | February 3, 2022

Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | January 26, 2022


LAKEWOOD, Colo., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 15, 2022, to shareholders of record at the close of business on February 28, 2022. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacturing of life science tools and critical quality

Yahoo | January 6, 2022

Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare

Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare

Yahoo | December 21, 2021

My 3 Favorite Under-the-Radar Healthcare Stocks for 2022

Looking for investment opportunities in the healthcare sector, and particularly in the biotechnology industry, can be overwhelming if you're not intimately familiar with the space. Here are three companies that operate surprisingly diverse operations -- either through drug pipeline variety, customer diversification, or differentiated product verticals -- offering a safety net, as well as prospects for growth, to their shareholders as a result. Led by its mission "to help people access, understand, and benefit from the human genome," 23andMe Holding (NASDAQ: ME) has quietly identified over 40 therapeutic programs from its treasure trove of genetic data.

Yahoo | December 21, 2021

What History Shows Us About 2022 Market Returns

What to Expect From the Markets In 2022

Yahoo | December 20, 2021

Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Yahoo | December 20, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6714 seconds.